Authors:
Bjorkstrand, B
Svensson, H
Goldschmidt, H
Ljungman, P
Apperley, J
Mandelli, F
Marcus, R
Boogaerts, M
Alegre, A
Remes, K
Cornelissen, JJ
Blade, J
Lenhoff, S
Iriondo, A
Carlson, K
Volin, L
Littlewood, T
Goldstone, AH
San Miguel, J
Schattenberg, A
Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515
Authors:
Stewart, M
Baker, RP
Bayliss, R
Clayton, L
Grant, RP
Littlewood, T
Matsuura, Y
Citation: M. Stewart et al., Molecular mechanism of translocation through nuclear pore complexes duringnuclear protein import, FEBS LETTER, 498(2-3), 2001, pp. 145-149
Authors:
Alunni-Fabbroni, M
Littlewood, T
Deleu, L
Caldeira, S
Giarre, M
Dell'Orco, M
Tommasino, M
Citation: M. Alunni-fabbroni et al., Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts, ONCOGENE, 19(19), 2000, pp. 2277-2285
Citation: R. Bayliss et al., Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking, CELL, 102(1), 2000, pp. 99-108
Authors:
Schuh, A
Atoyebi, W
Littlewood, T
Hatton, C
Bradburn, M
Murphy, MF
Citation: A. Schuh et al., Prevention of worsening of severe thrombocytopenia after red cell transfusions by the use of leucocyte-depleted blood, BR J HAEM, 108(2), 2000, pp. 455-457
Authors:
Pelengaris, S
Littlewood, T
Khan, M
Elia, G
Evan, G
Citation: S. Pelengaris et al., Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion, MOL CELL, 3(5), 1999, pp. 565-577
Authors:
Klefstrom, J
Kovanen, PE
Somersalo, K
Hueber, AO
Littlewood, T
Evan, GI
Greenberg, AH
Saksela, E
Timonen, T
Alitalo, K
Citation: J. Klefstrom et al., c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors, ONCOGENE, 18(13), 1999, pp. 2181-2188